Braud E - Search Results

1

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.

Hubbard KP, Pazdur R, Ajani JA, Braud E, Blaustein A, King M, Llenado-Lee M, Winn R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: braud e. Am J Clin Oncol. 1992 Dec;15(6):524-7. Am J Clin Oncol. 1992. PMID: 1449117 Clinical Trial.

2

Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.

Ravandi F, Rytting ME, Osmon C, Braud EL, Roach RW, Edwards K, Winn R, Abbruzzese JL, Pazdur R. Ravandi F, et al. Among authors: braud el. Anticancer Drugs. 1999 Jul;10(6):519-24. doi: 10.1097/00001813-199907000-00002. Anticancer Drugs. 1999. PMID: 10885898 Clinical Trial.

3

A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study.

Stiff PJ, McKenzie RS, Potempa LD, Albain K, Koch D, Braud E, Bansal VK, Weidner MK, Lanzotti VJ, Chun HG, et al. Stiff PJ, et al. Among authors: braud e. J Clin Oncol. 1991 Aug;9(8):1487-94. doi: 10.1200/JCO.1991.9.8.1487. J Clin Oncol. 1991. PMID: 2072148 Clinical Trial.

4

Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study.

Araujo JC, Mathew P, Armstrong AJ, Braud EL, Posadas E, Lonberg M, Gallick GE, Trudel GC, Paliwal P, Agrawal S, Logothetis CJ. Araujo JC, et al. Among authors: braud el. Cancer. 2012 Jan 1;118(1):63-71. doi: 10.1002/cncr.26204. Epub 2011 Jul 25. Cancer. 2012. PMID: 21976132 Free PMC article. Clinical Trial.

5

A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study.

Kuzel TM, Tallman MS, Shevrin D, Braud E, Kilton L, Johnson P, Kozlowski J, Vogelzang NJ, Blough R, Benson AB 3rd. Kuzel TM, et al. Among authors: braud e. Cancer. 1993 Sep 15;72(6):1965-8. doi: 10.1002/1097-0142(19930915)72:6<1965::aid-cncr2820720629>3.0.co;2-x. Cancer. 1993. PMID: 8364875 Clinical Trial.

6

Contrast medium "recalls" interleukin-2 toxicity.

Oldham RK, Brogley J, Braud E. Oldham RK, et al. Among authors: braud e. J Clin Oncol. 1990 May;8(5):942-3. doi: 10.1200/JCO.1990.8.5.942. J Clin Oncol. 1990. PMID: 2332778 No abstract available.

7

Autologous stem cell transplantation using peripheral blood stem cells.

Stiff PJ, Koester AR, Eagleton LE, Hindman T, Braud E, Weidner MK. Stiff PJ, et al. Among authors: braud e. Transplantation. 1987 Oct;44(4):585-8. doi: 10.1097/00007890-198710000-00030. Transplantation. 1987. PMID: 2890227 No abstract available.

8

NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives.

Zelenetz AD, Ahmed I, Braud EL, Cross JD, Davenport-Ennis N, Dickinson BD, Goldberg SE, Gottlieb S, Johnson PE, Lyman GH, Markus R, Matulonis UA, Reinke D, Li EC, DeMartino J, Larsen JK, Hoffman JM. Zelenetz AD, et al. Among authors: braud el. J Natl Compr Canc Netw. 2011 Sep;9 Suppl 4:S1-22. doi: 10.6004/jnccn.2011.0136. J Natl Compr Canc Netw. 2011. PMID: 21976013

9

Use of off-label drugs in cancer care again under review.

Braud E, Downs CG. Braud E, et al. ONS News. 2005 Mar;20(3):8. ONS News. 2005. PMID: 15794064 No abstract available.

10

Halo-1,2,3-triazoles: Valuable Compounds to Access Biologically Relevant Molecules.

Coelho D, Colas Y, Ethève-Quelquejeu M, Braud E, Iannazzo L. Coelho D, et al. Among authors: braud e. Chembiochem. 2024 May 17;25(10):e202400150. doi: 10.1002/cbic.202400150. Epub 2024 Apr 22. Chembiochem. 2024. PMID: 38554039 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters